Remy Cointreau (0MGU)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 51.83 |
|---|---|
| 52-week range | 34.18 – 51.83 |
| Return, 1 month / 3 months | +17.8% / +15.2% |
| Return, 1 year / 3 years | +3.3% / −54.2% |
| Trend | Uptrend |
| RSI (14) | 75 |
| Volatility (1 year) | 35.3% |
| Worst drawdown (1 year) | -29.4% |
| Average daily value traded | 0.75M EUR |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Remy Cointreau is a French spirits company based in Cognac that makes and markets cognac, most notably through its Remy Martin brand, along with orange liqueur under the Cointreau name and a range of other spirits. Its customers are drinkers around the world, reached through distributors, retailers, bars and restaurants, with a strong presence in international export markets.
On this site Remy Cointreau appears as a stock on the London Exchange (UK), code 0MGU, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Remy Cointreau (0MGU) trades on the London Exchange in UK. It last closed at EUR 51.83 on 22 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 1,317 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.3% and over the last three months it rose 15.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.7% | ||
| From 52-week high | 0.0% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 15.2% | ||
| 6-month return | 28.1% | ||
| 12-month return, skipping the last month | -12.3% | ||
| Stability (higher is calmer) | 50 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.4% | ||
| Liquidity | 50 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.75M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 24 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.6% |
|---|---|
| 1 month | +17.8% |
| 3 months | +15.2% |
| 6 months | +28.1% |
| 1 year | +3.3% |
| 3 years | −54.2% |
| 5 years | −68.7% |
Signals
| 50-day / 200-day average | 44.87 / 42.23 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.73 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Jul 2026 | EUR 0.2500 |
| 28 Jul 2025 | EUR 1.0000 |
| 24 Jul 2024 | EUR 2.0000 |
| 28 Sep 2023 | EUR 1.0000 |
| 27 Jul 2022 | EUR 1.8500 |
| 29 Sep 2021 | EUR 1.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.